FDA — authorised 9 October 1957
- Marketing authorisation holder: GLAXOSMITHKLINE
- Status: approved
FDA authorised Isopropamid on 9 October 1957
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 9 October 1957.
GLAXOSMITHKLINE holds the US marketing authorisation.